Coulter Partners

About Us

We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.

Achievements

Recent Placements

Coulter Partners

Find a Recruiter

0

The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.

Our Team

Coulter Partners

Solutions And Expertise

Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database.  Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.

Solutions
  • Advisory Services
  • Assessment
  • Board Services
  • Culture Shaping
  • Data Analy./Mrkt. Intell.
  • Diversity & Inclusion
  • Executive Coaching
  • Executive Search
  • Leadership Consulting
  • Leadership Develop.
  • Mgmt. Consulting
  • Onboarding
  • Recruitment Research
  • Succession Planning
Industries
  • Agriculture
  • Biotechnology
  • Chemicals
  • Clean Tech./Sustain.
  • Clinical Research
  • Consulting
  • Consumer
  • Consumer Products
  • Consumer Services
  • Data & Analytics
  • Devices
  • Energy
  • Family Offices
  • Financial Services
  • FinTech
  • Foundations
  • Healthcare Services
  • High Tech
  • Industrial
  • Industrial Products
  • Internet
  • Life Sci./Healthcare
  • Machine Learning
  • Medical
  • Medical Devices
  • Natural Resources
  • Non-Profit
  • Pharmaceuticals
  • Private Equity
  • Professional Services
  • Software
  • Supply Chain
  • Technology
  • Venture Capital
Functions
  • Board/Governance
  • Business Development
  • CEO/President
  • Data/Analytics
  • Diversity & Inclusion
  • Finance/Accounting
  • General Management
  • GM/Operations
  • Human Resources
  • Information/Digital
  • Investor Relations
  • Legal/Compliance
  • Manufacturing
  • Marketing & Sales
  • Medical/Clinical
  • Research & Develop.
  • Supply Chain

Coulter Partners

News Briefings

Coulter Partners Fills CFO and Non-Executive Director Positions for Optimapharm

Life sciences search specialist Coulter Partners has placed Walter Miller as chief finance officer and Charles Woler as non-executive director of Optimapharm. Directors Mark Sharp and Irene Montgomery led the assignment. “It has been a privilege to partner with Optimapharm on two more key search assignments, following our collaboration to bring Andrew Copestake on board as CEO

Coulter Partners Places New CEO of ObsEva

Life sciences search specialist Coulter Partners has placed Brian O’Callaghan as chief executive officer of ObsEva, a clinical-stage biopharmaceutical company developing and commercializing novel therapies for women’s reproductive health. Client partner Nona Footz led the assignment. Mr. O’Callaghan succeeds Ernest Loumaye, who co-founded the firm in 2012. As ObsEva evolves from a development company toward

Coulter Partners Forms Alliance with BioInnovation Institute

Life sciences search specialist Coulter Partners has formed a partnership with BioInnovation Institute (BII), the international incubator in Denmark for research-based innovation and entrepreneurship. The firm has been engaged to provide support for BII across three workstreams: providing assessment, coaching and development for the CEOs of start-up businesses in BII’s portfolio under the Creation House

Coulter Partners Hires U.S. Operations Director, Four Other Executives

The demand for talent in the life sciences sector has fueled continued growth at global executive search firm Coulter Partners. In many ways, the global pandemic has expanded the need for skilled leaders across the sector. To help manage its growth, the firm recently hired Marianne McNamara as operations director for the U.S. Also joining

Coulter Partners

Press Releases

Coulter Partners Successfully Places Chief Development Officer in the US for UK Biotech Company CellCentric

Coulter Partners recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based. CellCentric’s mission is to transform outcomes for people living with specific cancers, notably relapsed refractory multiple myeloma, as quickly and effectively as possible. The clinical-stage

Coulter Partners Places Three Key Executives at Australian Life Sciences Company, QBiotics Group Ltd

Coulter Partners recently partnered with QBiotics Group Limited (QBiotics) and is pleased to announce the placement of Stephen Doyle as Chief Executive Officer, and of two Non-executive Directors to its Board, namely Mark Fladrich and David Phillips QBiotics is an unlisted public Australian life sciences company that specializes in the discovery and development of novel

Coulter Partners Strengthens Executive and Leadership Team at Compass Pathways plc with Two Placements: Chairman of the Board and Chief R&D Officer

Coulter Partners recently partnered with Compass Pathways (Nasdaq: CMPS) (“Compass”) and is pleased to announce the placement of Gino Santini as Chairman of its Board of Directors and Michael Gold, MD as Chief Research and Development Officer. Compass is a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health. The Company is

Coulter Partners places Chief Executive Officer at Tristel plc

Coulter Partners recently partnered with Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, and is pleased to announce the placement of Matthew (“Matt”) Sassone as Chief Executive Officer (“CEO”) and to the Tristel Board, with effect from 2 September 2024. Matt will replace Paul Swinney, the Company’s founder and CEO of 30 years,

Coulter Partners Places Industry Veteran Dr. David Hung as Chair of T-Therapeutics

Coulter Partners recently partnered with T-Therapeutics and is pleased to announce the placement of David Hung as Chair of its Board of Directors. The biopharma industry veteran, founder of Medivation, and serial entrepreneur joins T-Therapeutics to support the development of the biotechnology company’s pipeline of next-generation soluble TCR therapeutics targeting cancer and autoimmune indications. Dr.